BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12810661)

  • 1. The G2-phase decatenation checkpoint is defective in Werner syndrome cells.
    Franchitto A; Oshima J; Pichierri P
    Cancer Res; 2003 Jun; 63(12):3289-95. PubMed ID: 12810661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines.
    Nakagawa T; Hayashita Y; Maeno K; Masuda A; Sugito N; Osada H; Yanagisawa K; Ebi H; Shimokata K; Takahashi T
    Cancer Res; 2004 Jul; 64(14):4826-32. PubMed ID: 15256452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Werner's syndrome protein is phosphorylated in an ATR/ATM-dependent manner following replication arrest and DNA damage induced during the S phase of the cell cycle.
    Pichierri P; Rosselli F; Franchitto A
    Oncogene; 2003 Mar; 22(10):1491-500. PubMed ID: 12629512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Werner's syndrome lymphoblastoid cells are hypersensitive to topoisomerase II inhibitors in the G2 phase of the cell cycle.
    Pichierri P; Franchitto A; Mosesso P; Proietti de Santis L; Balajee AS; Palitti F
    Mutat Res; 2000 Mar; 459(2):123-33. PubMed ID: 10725663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 modulates RPA-dependent and RPA-independent WRN helicase activity.
    Sommers JA; Sharma S; Doherty KM; Karmakar P; Yang Q; Kenny MK; Harris CC; Brosh RM
    Cancer Res; 2005 Feb; 65(4):1223-33. PubMed ID: 15735006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo function of the conserved non-catalytic domain of Werner syndrome helicase in DNA replication.
    Sharma S; Sommers JA; Brosh RM
    Hum Mol Genet; 2004 Oct; 13(19):2247-61. PubMed ID: 15282207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic cooperation between the Werner syndrome protein and poly(ADP-ribose) polymerase-1 in preventing chromatid breaks, complex chromosomal rearrangements, and cancer in mice.
    Lebel M; Lavoie J; Gaudreault I; Bronsard M; Drouin R
    Am J Pathol; 2003 May; 162(5):1559-69. PubMed ID: 12707040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional role of the Werner syndrome RecQ helicase in human fibroblasts.
    Dhillon KK; Sidorova J; Saintigny Y; Poot M; Gollahon K; Rabinovitch PS; Monnat RJ
    Aging Cell; 2007 Feb; 6(1):53-61. PubMed ID: 17266675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Werner syndrome protein: an update.
    Oshima J
    Bioessays; 2000 Oct; 22(10):894-901. PubMed ID: 10984715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct functions for WRN and TP53 in a shared pathway of cellular response to 1-beta-D-arabinofuranosylcytosine and bleomycin.
    Poot M; Jin X; Hill JP; Gollahon KA; Rabinovitch PS
    Exp Cell Res; 2004 Jun; 296(2):327-36. PubMed ID: 15149862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Werner protein stimulates topoisomerase I DNA relaxation activity.
    Laine JP; Opresko PL; Indig FE; Harrigan JA; von Kobbe C; Bohr VA
    Cancer Res; 2003 Nov; 63(21):7136-46. PubMed ID: 14612507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Werner syndrome protein confers resistance to the DNA lesions N3-methyladenine and O6-methylguanine: implications for WRN function.
    Blank A; Bobola MS; Gold B; Varadarajan S; D Kolstoe D; Meade EH; Rabinovitch PS; Loeb LA; Silber JR
    DNA Repair (Amst); 2004 Jun; 3(6):629-38. PubMed ID: 15135730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Werner syndrome protein prevents DNA breaks upon chromatin structure alteration.
    Turaga RV; Massip L; Chavez A; Johnson FB; Lebel M
    Aging Cell; 2007 Aug; 6(4):471-81. PubMed ID: 17521388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Werner syndrome protein contributes to induction of p53 by DNA damage.
    Blander G; Zalle N; Leal JF; Bar-Or RL; Yu CE; Oren M
    FASEB J; 2000 Nov; 14(14):2138-40. PubMed ID: 11023999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human decatenation checkpoint.
    Deming PB; Cistulli CA; Zhao H; Graves PR; Piwnica-Worms H; Paules RS; Downes CS; Kaufmann WK
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12044-9. PubMed ID: 11593014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-mediated apoptosis is attenuated in Werner syndrome cells.
    Spillare EA; Robles AI; Wang XW; Shen JC; Yu CE; Schellenberg GD; Harris CC
    Genes Dev; 1999 Jun; 13(11):1355-60. PubMed ID: 10364153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity.
    Crabbe L; Verdun RE; Haggblom CI; Karlseder J
    Science; 2004 Dec; 306(5703):1951-3. PubMed ID: 15591207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of WRN results in extensive deletion at nonhomologous joining ends.
    Oshima J; Huang S; Pae C; Campisi J; Schiestl RH
    Cancer Res; 2002 Jan; 62(2):547-51. PubMed ID: 11809708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaboration of Werner syndrome protein and BRCA1 in cellular responses to DNA interstrand cross-links.
    Cheng WH; Kusumoto R; Opresko PL; Sui X; Huang S; Nicolette ML; Paull TT; Campisi J; Seidman M; Bohr VA
    Nucleic Acids Res; 2006; 34(9):2751-60. PubMed ID: 16714450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Werner syndrome protein homolog affects C. elegans development, growth rate, life span and sensitivity to DNA damage by acting at a DNA damage checkpoint.
    Lee SJ; Yook JS; Han SM; Koo HS
    Development; 2004 Jun; 131(11):2565-75. PubMed ID: 15115755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.